425 related articles for article (PubMed ID: 29876600)
1. [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].
Aktas O; Wattjes MP; Stangel M; Hartung HP
Nervenarzt; 2018 Dec; 89(12):1344-1354. PubMed ID: 29876600
[TBL] [Abstract][Full Text] [Related]
2. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
3. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change.
Hartung HP; Graf J; Aktas O; Mares J; Barnett MH
Curr Opin Neurol; 2019 Jun; 32(3):327-337. PubMed ID: 30985371
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
[TBL] [Abstract][Full Text] [Related]
6. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
Alves Do Rego C; Collongues N
Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
10. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric study.
Weber J; Bernsdorff N; Robinson T; Endres D; Rauer S; Berger B
J Neurol Sci; 2021 Feb; 421():117289. PubMed ID: 33360733
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease.
Filippi M; Preziosa P; Margoni M; Rocca MA
Neuroimaging Clin N Am; 2024 Aug; 34(3):293-316. PubMed ID: 38942518
[TBL] [Abstract][Full Text] [Related]
14. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of opticospinal multiple sclerosis (OSMS) presentation detecting anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
Kitagawa S; Osada T; Kaneko K; Takahashi T; Suzuki N; Nakahara J
Rinsho Shinkeigaku; 2018 Dec; 58(12):737-744. PubMed ID: 30487359
[TBL] [Abstract][Full Text] [Related]
19. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
Fadda G; Brown RA; Longoni G; Castro DA; O'Mahony J; Verhey LH; Branson HM; Waters P; Bar-Or A; Marrie RA; Yeh EA; Narayanan S; Arnold DL; Banwell B;
Lancet Child Adolesc Health; 2018 Mar; 2(3):191-204. PubMed ID: 30169254
[TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
